期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
Tunable emission of cadmium-free transition metal(Cu, Mn, Ag) co-doped ZnInS/ZnS core-shell quantum dots
1
作者 Qiu-hang CHEN Shi-liang MEI +4 位作者 Wu YANG wan-lu zhang Gui-lin zhang Jia-tao ZHU Rui-qian GUO 《Transactions of Nonferrous Metals Society of China》 SCIE EI CAS CSCD 2018年第8期1611-1617,共7页
Color tunable quantum dots(QDs) based on the Cu, Mn, Ag co-doped Zn In S core and Zn S outer-shell were synthesized by using an eco-friendly method. Core-shell doped QDs with the average size of 3.85 nm were obtaine... Color tunable quantum dots(QDs) based on the Cu, Mn, Ag co-doped Zn In S core and Zn S outer-shell were synthesized by using an eco-friendly method. Core-shell doped QDs with the average size of 3.85 nm were obtained by using a one-pot synthesis followed by a hot injection with n-dodecanethiol(DDT) and oleylamine(OLA) as stabilizers in oil phase. Cu, Mn and Ag ions were introduced as single-dopant or co-dopants during the synthesis, providing an effective means to control the emission color of the QDs. The as-synthesized QDs showed photoluminescence emission ranging from green(530 nm) to near-red(613 nm), adjusted by doping components, dopant concentration, and Zn/In ratio. Importantly, quasi-white emission has been achieved by controlling the concentration of co-doped metal ions(Mn, Cu and Ag). The primary results demonstrated the promising potential of co-doped QDs as alternative materials for future high quality white LED applications. 展开更多
关键词 zinc group quantum dots CORE-SHELL doping tunable emission white light
在线阅读 下载PDF
Targeted treatments of psoriasis vulgaris recommended by guidelines
2
作者 wan-lu zhang Ying-Da Wu +1 位作者 Ping Cheng Cheng-Rang Li 《International Journal of Dermatology and Venereology》 2018年第3期141-150,共10页
Introduction Psoriasis is a common chronic recurrent inflammatory skin disease with most common clinical form of chronic plaque type (90%).For moderate-to-severe psoriasis vulgaris patients,who were inadequately respo... Introduction Psoriasis is a common chronic recurrent inflammatory skin disease with most common clinical form of chronic plaque type (90%).For moderate-to-severe psoriasis vulgaris patients,who were inadequately responding to other synthetic therapies,targeting therapeutic drugs may have unexpected effects.And with the deepening understanding of pathogenesis,the targeted therapy for psoriasis is increasingly diverse and accurate.Biologic agents can block T cell activation,antagonise T cell secretion of tumor necrosis factor alpha (TNF-α),interleukin (IL)-17,IL-23,and other cytokines,and then effectively block the immune inflammatory response. 展开更多
关键词 TARGETED TREATMENTS PSORIASIS VULGARIS GUIDELINES
原文传递
Disseminated pyoderma gangrenosum with oral involvement:successful treatment with systemic steroids and cyclosporine
3
作者 Wen-Rui Li Bao-Shu Sun +4 位作者 Nan Sheng Si-Jia Zhao wan-lu zhang Lin Lin Cheng-Rang Li 《International Journal of Dermatology and Venereology》 2018年第4期246-248,共3页
Introduction Pyoderma gangrenosum (PG) is a chronic skin disease characterized by progressive lesions that present as painful suppurative ulcers and tend to recur. The pathogenesis of the disease is incompletely under... Introduction Pyoderma gangrenosum (PG) is a chronic skin disease characterized by progressive lesions that present as painful suppurative ulcers and tend to recur. The pathogenesis of the disease is incompletely under-stood;however, 50%to 70%of affected persons have an associated concomitant systemic disease such as inflammatory bowel disease (IBD) (1)Any site of the body can be affected;however, involvement of the oropharynx is rare. Here, we present a patient with disseminated PG with oropharyngeal involvement. 展开更多
关键词 PYODERMA gangrenosum CHRONIC skin disease
原文传递
Dowling-Degos disease:current research progress
4
作者 Ying-Da Wu Wen-Rui Li +2 位作者 wan-lu zhang Ping Cheng Cheng-Rang Li 《International Journal of Dermatology and Venereology》 2018年第4期208-211,共4页
Introduction Dowling-Degos disease (DDD) was first described as a benign form of acanthosis nigricans by Dowling and Freudenthal in 1938, then referred to as'dermatose reticulée des plis'by Degos and Ossi... Introduction Dowling-Degos disease (DDD) was first described as a benign form of acanthosis nigricans by Dowling and Freudenthal in 1938, then referred to as'dermatose reticulée des plis'by Degos and Ossipowski in 1954, and was first named DDD by Wilson-Jones and Grice in 1978(1)The disease has been reported worldwide and affects both genders equally. As an autosomal dominant pigment disorder, it usually occurs in post-pubertal individuals, and is seldom seen in children(2)However, a Chinese newborn with DDD was reported in 2008(3)In this review, we summarize features of DDD, emphasizing advances in genetics research and looking to the future for further understanding of its etiology and the development of therapeutic methods. 展开更多
关键词 Dowling-Degos DISEASE acanthosis nigricans
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部